Johnson & Johnson (JNJ) 100.16 $JNJ
Final Glance: Pharmaceuticals companies
AP - Mon Aug 04, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Aug 04, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 2:40PM CDT
Alkermes (ALKS) incurred loss in the quarter due to higher expenses.
Midday Glance: Pharmaceuticals companies
AP - Mon Aug 04, 12:26PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Aug 04, 12:26PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Amgen Cancer Drug Kyprolis Succeeds In Trial
at Investor's Business Daily - Mon Aug 04, 9:56AM CDT
Big biotech Amgen (AMGN) early Monday reported positive interim results from a crucial late-stage trial of blood-cancer drug Kyprolis Monday, helping justify its $10 billion acquisition of Onyx last year. Amgen was up more than 1% in early trading in...
Early Glance: Medical Devices companies
AP - Mon Aug 04, 9:32AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Aug 04, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen
PR Newswire - Mon Aug 04, 7:50AM CDT
Today, Analysts Review released its research reports regarding Bristol-Myers Squibb Co. (NYSE: BMY), Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), Pharmacyclics Inc. (NASDAQ: PCYC) and Amgen Inc. (NASDAQ: AMGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5355-100free.
Asia at Center of Global Wound Care Market Growth to 2019 Says a New Research Report Available with LifeScienceIndustryResearch.com
PR Newswire Europe - Sun Aug 03, 1:01PM CDT
DALLAS, August 3, 2014 /PRNewswire/ --
Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 4:10PM CDT
Pharmacyclics (PCYC) reported better than expected revenues on strong Imbruvica sales.
J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments
PRWeb - Fri Aug 01, 3:45PM CDT
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices and drugs reports that Johnson & Johnson announced it would be recalling its Ethicon surgical power morcellator devices used for the removal of fibroid masses. The device maker sited concerns involving the spread of cancer associated with power morcellators, according to a Reuters report dated July 31, 2014.
Pharmacyclics Q2 Earnings Get Mixed Reception
at Investor's Business Daily - Fri Aug 01, 11:35AM CDT
Biotech Pharmacyclics (PCYC) was seesawing on the stock market today after its Q2 sales beat consensus late Thursday, but the company declined to update its guidance. Pharmacyclics' sales more than doubled over the year-earlier quarter to $113...
Final Glance: Pharmaceuticals companies
AP - Mon Aug 04, 5:03PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Mon Aug 04, 5:03PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 2:40PM CDT
Alkermes (ALKS) incurred loss in the quarter due to higher expenses.
Midday Glance: Pharmaceuticals companies
AP - Mon Aug 04, 12:26PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Mon Aug 04, 12:26PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Amgen Cancer Drug Kyprolis Succeeds In Trial
at Investor's Business Daily - Mon Aug 04, 9:56AM CDT
Big biotech Amgen (AMGN) early Monday reported positive interim results from a crucial late-stage trial of blood-cancer drug Kyprolis Monday, helping justify its $10 billion acquisition of Onyx last year. Amgen was up more than 1% in early trading in...
Early Glance: Medical Devices companies
AP - Mon Aug 04, 9:32AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Mon Aug 04, 9:32AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen
PR Newswire - Mon Aug 04, 7:50AM CDT
Today, Analysts Review released its research reports regarding Bristol-Myers Squibb Co. (NYSE: BMY), Johnson & Johnson (NYSE: JNJ), Merck & Co., Inc. (NYSE: MRK), Pharmacyclics Inc. (NASDAQ: PCYC) and Amgen Inc. (NASDAQ: AMGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5355-100free.
Asia at Center of Global Wound Care Market Growth to 2019 Says a New Research Report Available with LifeScienceIndustryResearch.com
PR Newswire Europe - Sun Aug 03, 1:01PM CDT
DALLAS, August 3, 2014 /PRNewswire/ --
Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 01, 4:10PM CDT
Pharmacyclics (PCYC) reported better than expected revenues on strong Imbruvica sales.
J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments
PRWeb - Fri Aug 01, 3:45PM CDT
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices and drugs reports that Johnson & Johnson announced it would be recalling its Ethicon surgical power morcellator devices used for the removal of fibroid masses. The device maker sited concerns involving the spread of cancer associated with power morcellators, according to a Reuters report dated July 31, 2014.
Pharmacyclics Q2 Earnings Get Mixed Reception
at Investor's Business Daily - Fri Aug 01, 11:35AM CDT
Biotech Pharmacyclics (PCYC) was seesawing on the stock market today after its Q2 sales beat consensus late Thursday, but the company declined to update its guidance. Pharmacyclics' sales more than doubled over the year-earlier quarter to $113...
